Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumors

12 Jul 2016

Abstract excerpt

// Lynsey Vaughan 1,9 , Paul A. Clarke 2 , Karen Barker 1 , Yvan Chanthery 3 , Clay W. Gustafson 3 , Elizabeth Tucker 1 , Jane Renshaw 1 , Florence Raynaud 4 , Xiaodun Li 1,11 , Rosemary Burke 5 , Yann Jamin 6 , Simon P. Robinson 6 , Andrew Pearson 1 , Michel Maira 7,10 , William A. Weiss 3 , Paul Workman 2 and Louis Chesler 1,2,8 1 Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Neuroblastoma Research and Treatments
Share to Protein Degradation and Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27438153
DOI: 10.18632/oncotarget.10544

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumorsPMID 27438153Read ↗

Targeting MYCN in Molecularly Defined Malignant Brain TumorsSemantic proximity Read ↗

Taking on challenging targets: making MYC druggable.Semantic proximity Read ↗

MYC modulators in cancer: a patent reviewSemantic proximity Read ↗

Alternative approaches to target Myc for cancer treatmentSemantic proximity Read ↗

Strategies to target the cancer driver MYC in tumor cellsSemantic proximity Read ↗

Integrative omics reveals MYCN as a global suppressor of cellular signalling and enables network-based therapeutic target discovery in neuroblastomaSemantic proximity Read ↗

New strategies in neuroblastoma: Therapeutic targeting of MYCN and ALK.Semantic proximity Read ↗

Orally bioavailable CDK9/2 inhibitor shows mechanism-based therapeutic potential in MYCN-driven neuroblastomaSemantic proximity Read ↗

Identification and Pharmacological Inactivation of the MYCN Gene Network as a Therapeutic Strategy for Neuroblastic Tumor CellsSemantic proximity Read ↗

Targeting Pathways in Neuroblastoma: Advances in Treatment Strategies and Clinical OutcomesSemantic proximity Read ↗

Aurora B kinase is a potent and selective target in MYCN-driven neuroblastomaSemantic proximity Read ↗

Targeting of the MYCN Protein with Small Molecule c-MYC InhibitorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.